PubMed bibliography
Selected publications
Boeve BF, Davis AA, Ju YE, Kantarci K, Singer W, Videnovic A. Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol. 2024 Jul;23(7):659-660.
Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS. Baseline characteristics of the North American prodromal Synucleinopathy cohort. Ann Clin Transl Neurol. 2023 Apr;10(4):520-535.
Smith SK, Tran P, Madden KA, Boyd J, Braun R, Musiek ES, Ju YS. Validation of blood-based transcriptomic circadian phenotyping in older adults. Sleep. 2022 Sep 8;45(9).
Xue B, Licis A, Boyd J, Hoyt CR, Ju YS. Validation of actigraphy for sleep measurement in children with cerebral palsy. Sleep Med. 2022 Feb;90:65-73.
Ambati A, Ju YE, Lin L, Olesen AN, Koch H, Hedou JJ, Leary EB, Sempere VP, Mignot E, Taheri S. Proteomic biomarkers of sleep apnea. Sleep. 2020 Nov 12;43(11). doi: 10.1093/sleep/zsaa086. PubMed PMID: 32369590; PubMed Central PMCID: PMC7686561.
Videnovic A, Ju YS, Arnulf I, Cochen-De Cock V, Högl B, Kunz D, Provini F, Ratti PL, Schiess MC, Schenck CH, Trenkwalder C. Clinical trials in REM sleep behavioural disorder: challenges and opportunities. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):740-749.
Ju YS, Zangrilli MA, Finn, MB, Fagan AM, Holtzman DM. Obstructive sleep apnea treatment, slow wave activity, and amyloid-β. Annals of Neurology 2018;85(2):291-295.
Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS. Circadian rest-activity pattern changes in aging and preclinical Alzheimer Disease. JAMA Neurology. 2018; 75(5):582-590.
Ju YS,* Ooms SJ,* Sutphen C, Macauley SL, Zangrilli M, Jerome G, Fagan AM, Mignot E, Zempel JM, Claassen JAHR, Holtzman DM. Slow wave sleep disruption increases cerebrospinal fluid amyloid-beta levels. Brain. 2017; 140(8):2104-2111.
Ju YS, Finn MB, Sutphen CL, Herries EM, Jerome GM, Ladenson JH, Crimmins DL, Fagan AM, Holtzman DM. Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid. Annals of Neurology. 2016; 80(1): 154-159.
Postuma RB, Iranzo A, Högl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YS, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, Semenescu M, Zucconi M, Terzaghi M, Miyamoto M, Unger M, Carlander B, Fantini M, Montplaisir J. Risk Factors for Neurodegeneration in Idiopathic RBD: A Multicenter Study. Annals of Neurology. 2015; 77(5): 830-839.
Ju YS, Lucey BP, Holtzman DM. Sleep and Alzheimer Disease pathology – a bidirectional relationship. Nature Reviews Neurology. 2014; 10(2): 115-119.
Frauscher B*, Jennum P*, Ju YS, et al. Comorbidity and medication in idiopathic REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014; 82(12): 1076-1079.
Ju YS, McLeland J, Toedebusch C, Xiong C, Fagan A, Duntley S, Morris J, Holtzman DH. Sleep quality and preclinical Alzheimer Disease. JAMA Neurology 2013; 70(5): 587-593.
Ju YS, Larson-Prior LJ, Duntley SP. Changing demographics in REM Sleep Behavior Disorder: possible effect of autoimmunity and antidepressants. Sleep Medicine 2011; 3: 278-83.